Understanding Insomnia Severity Index and Treatment…

What is the Insomnia Severity Index?

The Insomnia Severity Index (ISI) is a self-report questionnaire designed to assess the severity of insomnia. It consists of seven items, each rated on a scale from 0 to 4, with higher scores indicating more severe symptoms.

Developed by Richard Bootzin and colleagues in 1996, the ISI provides a reliable and valid measure for clinical practice and research studies.

How Does the ISI Respond to Treatment?

The response of the ISI to treatment can be quantified by changes in scores over time. A reduction in ISI scores indicates improvement, while an increase suggests worsening insomnia.

In this simulation, we focus on how orexin antagonists, a class of drugs that target the orexin system involved in sleep regulation, affect ISI scores.

live demo · related simulation● LIVE

Why Does It Matter?

Understanding the response of the ISI to treatment is crucial for evaluating the effectiveness of therapeutic interventions. This knowledge helps clinicians tailor treatments to individual patients and monitor progress over time.

Moreover, it aids in research studies by providing a standardized method to compare different treatments or patient groups.

Real-World Applications

The ISI is used in clinical settings to guide treatment decisions and assess the impact of interventions. For example, if a patient's ISI score drops significantly after starting orexin antagonist therapy, it suggests that the treatment is effective.

In research, changes in ISI scores can help identify new therapeutic targets or evaluate the long-term efficacy of treatments.

Frequently asked questions

What are orexin antagonists?

Orexin antagonists are drugs that block the action of orexins, which are neurotransmitters involved in regulating sleep-wake cycles. They help manage insomnia by promoting more restful and longer periods of sleep.

How is the ISI scored?

The ISI scores range from 0 to 28, with higher scores indicating greater severity of insomnia symptoms. A score below 10 typically indicates mild insomnia, while a score above 20 suggests severe insomnia.

Can other treatments affect the ISI besides orexin antagonists?

Yes, various treatments such as cognitive behavioral therapy for insomnia (CBT-I), sleep hygiene interventions, and other pharmacological therapies can also influence ISI scores. The simulation focuses on orexin antagonists but illustrates general principles applicable to many treatment modalities.

Is the ISI always accurate in measuring insomnia severity?

While the ISI is a reliable tool, its accuracy may vary depending on factors such as patient comprehension and honesty. Clinicians often use it alongside other assessments for a comprehensive evaluation of insomnia severity.

Try it live

Everything above runs in your browser — open Insomnia Severity Index Treatment Response Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Insomnia Severity Index Treatment Response Simulator simulation

Understanding Insomnia Severity Index and Treatment Response